The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

JUNE 4, 2021

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws.

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. Even if there’s an accurate diagnosis, many mental health treatments have less-than-desirable efficacy, and there can be significant side effects.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

NORML

JANUARY 28, 2020

Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. cannabis arrest data since 2008. cannabis arrest data since 2008.

Marijuana 296

Marijuana Data Decriminalization Policy 296

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior. About Realm of Caring.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Cannabis Law Report

MAY 26, 2022

Successful Behavioral Addiction Study Supplied Data for Patent. The successful completion of Awakn’s behavioral addictions study was announced last week and the data provided from the study was used in the patent filing. The treatment was also well tolerated with no safety concerns. Awakn Life Sciences Corp. (

Treatment 52

Treatment Research and Development Therapy Data 52

NORML

MARCH 23, 2020

The National Organization for the Reform of Marijuana Laws wishes to reiterate its message that cannabis consumers and others beware of online misinformation surrounding the use of either whole-plant cannabis or CBD as a potential remedy for the COVID-19 virus.

CBD 345

CBD Therapy Treatment Packaging 345

Cannabis Law Report

SEPTEMBER 17, 2021

HARRISBURG — The public could soon know for the first time how many patients use medical marijuana to treat opioid use disorder in Pennsylvania, one of the few states to specifically endorse that treatment option. Cordeiro died of an overdose a few weeks later. Yet, the director of the Office of Medical Marijuana, John J.

Treatment 52

Treatment Patients Data Policy 52

CannaMD

SEPTEMBER 15, 2020

What law legalized medical marijuana in Florida? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. How does Florida law define medical marijuana? So sit back, relax, and grab your notebook. Qualified patient.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

DECEMBER 20, 2021

So… what does “UAE eases drug laws: No more jail for those bringing in cannabis ingredient” actually mean? The UAE has eased some of its strict drug laws and lessened penalties for travellers, who arrive in the country with products containing Tetrahydrocannabinol (THC), the main active chemical in cannabis (hashish).

Law 52

Law Data Treatment Patients 52

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Why Do MMJ Patients Use Cannabis?

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Chronicles

MAY 22, 2019

The partnership between the land grant institution in Pullman and the Tacoma-based native tribe is intended to create a standard to evaluate treatment plans at a natural healing clinic the Puyallups opened in October, and to determine the effectiveness of the drug as an alternative to opioids in managing pain.

Medicine 140

Medicine Research and Development Data Collective 140

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Forward-Looking Statements.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

SEPTEMBER 30, 2021

Cannabis is an ideal substance to use during the various stages of cancer treatment but most especially after chemotherapy. The team of researchers analyzed data from nearly 20,000 people over a four-year period and found that cannabis use among cancer patients peaked at 9%.

Patients 98

Patients Research and Development Treatment Consumption 98

Peninsula Alternative Health

MARCH 1, 2018

The physician advocate outlines practice risks and benefits, educational requirements, compliance issues, and more for those interested in studying this alternative treatment. National Organization for the Reform of Marijuana Laws (NORML). National Cannabis Industry Association (NCIA). Based in Washington, D.C. The mission of this D.C.-based

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

The physician advocate outlines practice risks and benefits, educational requirements, compliance issues, and more for those interested in studying this alternative treatment. National Organization for the Reform of Marijuana Laws (NORML). National Cannabis Industry Association (NCIA). Based in Washington, D.C. The mission of this D.C.-based

Treatment 40

Treatment Education Advocacy Access 40

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

The Joint Blog

MAY 30, 2020

According to an interesting and for some eye-opening new study published in the journal Drug and Alcohol Dependence, the enactment of marijuana legalization laws is not associated with an increase in marijuana-related youth drug treatment admissions.

Treatment 26

Treatment Legalization Marijuana Recreational 26

Cannabis Law Report

FEBRUARY 14, 2020

Consumer products law blog. Class actions against CBD companies proliferate under federal and state law. However, according to the federal Food, Drug & Cosmetic Act and FDA regulations and guidance, CBD products cannot be marketed as food additives, dietary supplements, or for therapeutic uses and treatment of diseases.

State Laws 59

State Laws Law CBD Food 59

Veriheal

MARCH 29, 2023

The Relationship Between Marijuana Use and Psychosis Using the Optum Clinformatics DataMart Database , which functions as an anonymous Medicare Advantage and commercial claims database, scientists were able to gather data with unprecedented precision. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2

Legalization 57

Legalization Data Policy Cannabis 57

Cannabis Law Report

JUNE 23, 2021

. “We are excited to be initiating our pilot program with Medicann in Jersey, which represents a unique, ‘ring-fenced’ environment for establishing potentially numerous studies on the efficacy of treatments using plant-based therapies. About RYAH Group, Inc. RYAH Group, Inc. Forward-Looking Statements.

Programs 100

Programs Data Events Collective 100

CannaMD

MARCH 3, 2021

Law enforcement, policy makers, and public citizens have long debated how recreational marijuana legalization influences crime and public safety. Data tells us that more arrests for marijuana trafficking and possession occur after marijuana legalization in neighboring states, concentrated at the bordering counties.

Legalization 119

Legalization Marijuana Data Safety 119

Veriheal

DECEMBER 14, 2023

This stigma has been problematic for cannabis consumers for years and often leads to unfair stereotypes against people who benefit from cannabis treatment for mental or physical health issues. These stereotypes have consequences, whether political, legal, or within the medical system, and may prevent people from seeking care that can help.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

Veriheal

JUNE 19, 2023

The psychedelic drugs here include LSD, MDMA, psilocybin, ketamine, and ayahuasca, which are in high demand for mental health treatment and other therapeutic reasons. All the data provided by the report are validated and trustworthy and can be used to gain the upper hand in the industry. billion in the next six years. .”

Therapy 109

Therapy Treatment Patients Policy 109

CannaMD

JANUARY 6, 2021

Luckily, states such as Colorado, Washington, and California have had marijuana laws in place long enough for researchers to collect data and better understand the effects of legalization on behaviors such as driving under the influence. Their results may assuage some of these concerns. FACTORS INFLUENCING RESULTS. INADEQUATE TESTING.

Recreational 105

Recreational Marijuana Data Collective 105

Cannabis Law Report

DECEMBER 2, 2021

Equity subcommittee members raised concerns regarding the background check requirement, expressing worry such a requirement will disparately impact individuals from communities disproportionately targeted by law enforcement. An amendment to drop the background check requirement was proposed but failed to pass.

Law 52

Law Programs Therapy Education 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE:

Research and Development 105

Research and Development Data Conditions Therapy 105

SpeedWeed

APRIL 10, 2021

Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms,” was posted online last month prior to publication by the journal Experimental and Clinical Psychopharmacology. The data revealed a sustained improvement in the participants’ symptoms.

Chronic Pain 52

Chronic Pain Patients Treatment Data 52

Veriheal

MAY 19, 2023

SB 5132 already has a number of exceptions built-in for safety-sensitive jobs like law enforcement, firefighting, and first responders. The case report built off data self-study complied by an Institute colleague and combined it with past reports of colorblind individuals who experienced vision improvements after consuming psilocybin.

Chronic Pain 94

Chronic Pain Data Consumption Safety 94